Mobile-health Network's shares rose 370% to $4 per share, but the report gives no company news explaining the move. It does not change the business outlook.
A share-price move alone does not show that Mobile-health Network's sales, costs, or services changed. The article names no company announcement or business result behind it. That leaves no new reason to change the business outlook.
CervoMed's shares fell 20.94% to $2.55 per share, but the report gives no company news explaining the move. It does not change the business outlook.
Pomdoctor's shares fell 20.78% to $0.61 per share, but the report gives no company news explaining the move. It does not change the business outlook.
SCWorx's shares fell 20.65% to $2.96 per share, but the report gives no company news explaining the move. It does not change the business outlook.
XORTX Therapeutics' shares rose 24.11% to $1.75 per share, but the report gives no company news explaining the move. It does not change the business outlook.
CollPlant Biotechnologies' shares rose 21.79% to $4.28 per share, but the report gives no company news explaining the move. It does not change the business outlook.
Follow Mobile-health Network (MNDR) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for MNDR